Morgan Lewis

Life Sciences Related News

For More Information

Read the Brochure

Life Sciences and Healthcare

Life Sciences Deskbook

New Resource

New Resource: Health Industry Transparency Compliance Resource Center

Emerging Business Tools

visit the Entrepreneur Resource Headquarters

Practice Highlights

Honors

PLCCross-border Quarterly 2012 Life Sciences Legal Market Review

  • Life Sciences Regulatory Super League - Ranked 8th among law firms worldwide

PLCCross-border Life Sciences Handbook 2011/12

  • U.S.:
    • Commercial and Partnering - Highly Recommended
    • Competition/Antitrust - Highly Recommended
    • Corporate - Recommended
    • Government Enforcement and Investigations - Highly Recommended
    • Regulatory - Recommended
    • Regulatory (Medical Devices) - Recommended
  • England: Regulatory - Recommended
  • Japan: Corporate and Commercial - Recommended

Chambers Global 2011: Global Life Sciences - Recommended - Band 3

Chambers USA 2011: National for Life Sciences - Band 3; Washington, D.C. for healthcare/ pharmaceutical/ medical products regulatory - Band 3

UK Legal 500 2010: London: Pharmaceuticals and Biotechnology

Best Lawyers in America 2011: Biotechnology and Healthcare Law Named

BioPharm Insight 2011

  • Ranked 3rd - Global League Table of Legal Advisers on Licensing Agreements - Based upon Volume
  • Ranked 6th - Global League Table of Legal Advisers on Licensing Agreements - Based upon Value
  • Ranked 4th - League Table of Legal Advisers on North American Licensing Agreements - Based upon Volume
  • Ranked 9th - League Table of Legal Advisers on North American Licensing Agreements - Based upon Value
  • Ranked 3rd - League Table of Legal Advisers on European Licensing Agreements - Based upon Volume
  • Ranked 4th - League Table of Legal Advisers on European Licensing Agreements - Based upon Value
  • Ranked 2nd - League Table of Legal Advisers on Asia-Pacific Licensing Agreements - Based upon Volume
  • Ranked 5th - League Table of Legal Advisers on Asia-Pacific Licensing Agreements - Based upon Value
U.S. News & World Report/Best Lawyers 2010: Ranked Tier 1 National Practice - Biotechnology

Clients

16 of the top 20 pharmaceutical companies

7 of the top 20 biotechnology companies

9 of the top 20 medical device companies

Related Events

06/06/12-06/08/12 ABA’s Civil False Claims Act and Qui Tam Enforcement 2012
Katie McDermott, presenter, "Investigation of a False Claims Act Case"
06/06/12-06/07/12 2012 Health Law Institute in Minneapolis
Arianne Callender, speaker, "Fraud and Abuse Update"
06/09/12-06/12/12 The Business of Medicine 2012 San Diego Summit
Kathleen McDermott, presenter, "Shining a Light on the Sunshine Act: What You Need To Know"
View all events

Related News

05/04/12 Regulatory Policy: CBER Importance Boosted With Attention To Biologic Drugs, Biosimilars, Speakers Say
Life Sciences and Healthcare partner Stephen Paul Mahinka is quoted.
04/25/12 Q&A With Morgan Lewis' Randall Sunberg, Law360
Business and Finance partner Randall Sunberg is interviewed as part of Law360 's Q&A series.
04/05/12 Biosimilars Naming and Labeling: An FDLI Dialogue, Update Magazine
Life Sciences and Healthcare partner Stephen Paul Mahinka is quoted.
View all news

Related Publications

05/09/12 Eleventh Circuit Rejects FTC Challenge to Reverse Payment Settlement
Decision by court of appeals affirms that settlements that do not expand the exclusionary scope of a patent are not subject to antitrust challenge.
05/03/12 HHS Plugs Payment Suspensions as Key Tool in Latest Takedown
The Medicare Fraud Strike Force's use of a pivotal ACA regulation to suspend payments during criminal investigations signals a turning point in its prosecution strategy.
View all publications
37 news articles found
page 2 of 2
Dec 12, 2006 - Morgan Lewis Attorneys Assist in Obtaining Patent for Subject Matter of Nobel Prize

Morgan Lewis attorneys represented the Carnegie Institution of Washington before the U.S. Patent & Trademark Office in obtaining U.S. Patent 6,506,559, which claims the subject matter awarded the Nobel Prize in Medicine for 2006.

Nov 28, 2006 - Morgan Lewis Adds Five Partners to Global IP Group

Morgan Lewis is pleased to announce the addition of five partners and five associates to its global Intellectual Property Practice as of December 1.

Aug 15, 2006 - Significant Pharmaceutical Patent Litigation Win for Daiichi

On August 2, 2006, United States District Judge William Bassler entered a judgment on behalf of Morgan Lewis clients Daiichi Pharmaceutical Co., Ltd. and Daiichi Sankyo Inc.

Jul 11, 2006 - ABA Intellectual Property Law Section’s Resolution 413-1

On June 22, 2006 the Intellectual Property (IP) Law Section of the American Bar Association (ABA) held its summer meeting in Boston. Resolution 413-1, entitled State Prescription Drug Compulsory Licensing was presented, debated, and overwhelmingly passed.

Mar 29, 2006 - Morgan Lewis to Exhibit at BIO 2006

Morgan Lewis sponsors BIO 2006, the world's largest gathering of biotechnology leaders.

Dec 13, 2005 - Morgan Lewis’ Life Sciences Practice Recommended in PLC Cross-border Life Sciences Handbook

Morgan Lewis is pleased to announce that Practical Law Company recommends the firm’s Life Sciences Practice and its attorneys in the PLCCross-border Life Sciences Handbook 2005/06.

Sep 28, 2005 - Morgan Lewis Announces New Joint Venture with TMI Associates, The Sixth Largest Law Firm in Japan

Morgan Lewis & Bockius LLP, a global law firm, today announced a new joint venture with TMI Associates, one of the top law firms in Japan, effective immediately. The new partnership, named Morgan Lewis-TMI, will focus primarily on cross-border corpora

Feb 09, 2004 - Morgan Lewis Expands Life Science Practice Capabilities
Oct 06, 2003 - Former Pharmacia General Counsel Richard T. Collier Joins Morgan Lewis
Dec 02, 2002 - Morgan Lewis Represents Enzon in $360 Million Purchase of Abelcet® North American Business From Elan
Apr 09, 2002 - Morgan Lewis London Partner Named Leading Life Sciences Lawyer
Jun 11, 2001 - Morgan Lewis Opens Northern Virginia Office and Extends Reach of Global Technology Practice
page 2 of 2